Phase IIa proof-of-principle study for the induction treatment of autoimmune hepatitis using infliximab AIH-MAB
Latest Information Update: 18 Jun 2024
At a glance
- Drugs Infliximab (Primary)
- Indications Autoimmune hepatitis
- Focus Proof of concept; Therapeutic Use
- Acronyms AIH-MAB
- 16 Jun 2024 Status changed from recruiting to completed.
- 12 Jan 2018 New trial record